Author: James Love

The following is the KEI comment to the NIH proposed exclusive license to Great Lakes Neuroscience for a patent on Multiple Sclerosis, Amyotrophic Lateral Sclerosis and certain other CNS Disorders. (PDF version here). KEI asks the NIH for certain information about the proposed license, and also asks the NIH to include provisions in the license that protect consumers in both the United States and developing countries.

For the United States, KEI asks that prices be:

Continue Reading →

The Fordham international IP conference just concluded a panel on patents for second uses of medical inventions, and the discussions illustrated once more the degree to which the patent system is poorly designed to address this issue.

Continue Reading →

These were my notes from my talk on Thursday morning at the annual Fordham International IP conference, which is organized by Professor Hugh Hansen. The panel was titled “Examination of TPP & TTIP.”

What is wrong with the TransPacific Partnership (TPP)?

The TPP was negotiated with asymmetric secrecy. Not from industry, but from the public. Nearly all of the real experts in IP policy were in the dark over the actual language of the texts. We delegated too much power to government trade negotiators and to lobbyists.

Continue Reading →

This was the Wall Street Journal’s take on the Doha Declaration on TRIPS and Public Health, two days after the agreement was reached:

Continue Reading →

I have provided an update on our work on US government owned patents here:

• Your tax dollars at work: Licencing of patents on US government owned inventions: concerns about transparency, protection of public interest, Medium.Com, March 11, 2016.

Continue Reading →

Other KEI comments on NIH licenses can be found here: /nih-licenses

Continue Reading →

This is a slightly expanded version of the testimony we provided at the March 1, 2016 USTR Special 301 hearing. I had some trouble uploading to Regulations.Gov, but emailed a copy to Christine R. Peterson, the Director for Intellectual Property and Innovation. One addition was this data:

Continue Reading →

We sent this brief note to the Army today regarding this federal register note: https://federalregister.gov/a/2016-04494


From: Jamie Love
Date: Sat, Mar 5, 2016
To: Phoebe.E.Lenear@usace.army.mil
Subject: Digital Optical Method patents

I am writing about the notice of intent for an exclusive license to patents on the Digital Optical Method (DOMTM ), United States Patent No. 7,495,767.

Continue Reading →